Back to all event archives

202206 Ai Summit Logo

AI Summit 2022

The 2022 AI Summit attracted more than 95 participants who journeyed together through a wide range of topics, built bridges to different ideas and concepts and came away with action items and plans to move AI in healthcare forward.

If you are looking for solutions to launch and advance AI capabilities, join us next year.

Check out the AI Global Initiative here | Sign up for the AI Summit Mailing list

2022 Speaker Highlights

Bakul Patel

Bakul Patel

Senior Director, Global Digital Health Strategy & RegulatoryGoogle

Toni Manzano

Co-founder and CSO, Aizon

Pat Baird

Regulatory Head of Global Software Standards,

Jesse M. Ehrenfeld

President-Elect, American Medical Association

Jeff Ballyns

Associate Director Regulatory Policy, BD

Sundar Selvatharasu

Chief Compliance Officer – GxP Operations, Sierra Labs

Ling Koh

Regulatory Affairs Manager, BD

Eric Henry, King & Spalding

Eric Henry

Senior Quality & Regulatory Compliance Advisor, FDA & Life Sciences Practice, King & Spalding

A look back at the 2022 Summit

The 2022 summit was held in person in Columbus, Ohio — where we had a behind-the-scenes look into how Artificial Intelligence (AI) is being used in pharma, biopharma, and medical devices!

Featured Topics


QMS Case Study – A Real-World Experience Aligning AI/ML Activities with a Compliant QMS


Current AI Global Regulatory and Standards Landscape


Lessons Learned: Bringing an AI-Enabled Device to Market Through a Pandemic


Lessons Learned and Pitfalls When Deploying AI in GxP Environments


How AI Can Be Used in 3D Printing & Smart Manufacturing


Learn What the Industry-Led AI Working Teams Have Been Up To

Who attended the AI Summit?

Quality, regulatory, operations, and R&D professionals in the healthcare space

Healthcare professionals who are using or building AI solutions

Clinical trial managers

Biopharma and biotech professionals

Healthcare executives

Consultants and service providers to the life science industries

Data scientists and AI experts

This meeting is supported by the Food and Drug Administration (FDA) of the U.S. Department of Health and Human Services (HHS) as part of a financial assistance award FAIN R13FD007707 totaling $50,000 funded by FDA/HHS and $76,000 amount and funded by non-government source(s). The contents are those of the author(s) and do not necessarily represent the official views of, nor an endorsement, by FDA/HHS, or the U.S. Government.

The AFDO/RAPS Healthcare Products Collaborative is a joint venture established in 2022 between the Association of Food and Drug Officials and the Regulatory Affairs Professionals Society. Learn more.


Stay in the know about upcoming events and breaking news from the collaborative.



Have questions about our events or how to get involved with one of our committees or workgroups?

Get in touch

© 2024 AFDO/RAPS Healthcare Products Collaborative